Hypera S.A (HYPE3) - Total Liabilities
Based on the latest financial reports, Hypera S.A (HYPE3) has total liabilities worth R$16.27 Billion BRL (≈ $3.19 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore HYPE3 cash generation efficiency to assess how effectively this company generates cash.
Hypera S.A - Total Liabilities Trend (2005–2024)
This chart illustrates how Hypera S.A's total liabilities have evolved over time, based on quarterly financial data. Check HYPE3 financial resilience to evaluate the company's liquid asset resilience ratio.
Hypera S.A Competitors by Total Liabilities
The table below lists competitors of Hypera S.A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kaori Heat Treatment Co Ltd
TW:8996
|
Taiwan | NT$3.25 Billion |
|
Indah Kiat Pulp & Paper Tbk
JK:INKP
|
Indonesia | Rp5.77 Billion |
|
Amot Investments Ltd
TA:AMOT
|
Israel | ILA12.18 Billion |
|
Growthpoint Properties Ltd
JSE:GRT
|
South Africa | ZAC69.92 Billion |
|
Xiamen Xiangyu Co Ltd
SHG:600057
|
China | CN¥98.82 Billion |
|
Shanghai Mechanical & Electrical Industry Co Ltd A
SHG:600835
|
China | CN¥17.92 Billion |
|
LuxNet
TWO:4979
|
Taiwan | NT$1.64 Billion |
|
Gerdau S.A
SA:GGBR3
|
Brazil | R$32.52 Billion |
Liability Composition Analysis (2005–2024)
This chart breaks down Hypera S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Hypera S.A.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.37 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hypera S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hypera S.A (2005–2024)
The table below shows the annual total liabilities of Hypera S.A from 2005 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | R$12.46 Billion ≈ $2.44 Billion |
-4.11% |
| 2023-12-31 | R$12.99 Billion ≈ $2.55 Billion |
-0.83% |
| 2022-12-31 | R$13.10 Billion ≈ $2.57 Billion |
+31.21% |
| 2021-12-31 | R$9.98 Billion ≈ $1.96 Billion |
+24.66% |
| 2020-12-31 | R$8.01 Billion ≈ $1.57 Billion |
+149.55% |
| 2019-12-31 | R$3.21 Billion ≈ $629.74 Million |
+40.19% |
| 2018-12-31 | R$2.29 Billion ≈ $449.20 Million |
-4.32% |
| 2017-12-31 | R$2.39 Billion ≈ $469.49 Million |
-10.57% |
| 2016-12-31 | R$2.68 Billion ≈ $524.99 Million |
-65.67% |
| 2015-12-31 | R$7.79 Billion ≈ $1.53 Billion |
+21.54% |
| 2014-12-31 | R$6.41 Billion ≈ $1.26 Billion |
+18.22% |
| 2013-12-31 | R$5.42 Billion ≈ $1.06 Billion |
-6.30% |
| 2012-12-31 | R$5.79 Billion ≈ $1.14 Billion |
-13.34% |
| 2011-12-31 | R$6.68 Billion ≈ $1.31 Billion |
+35.54% |
| 2010-12-31 | R$4.93 Billion ≈ $966.98 Million |
+84.16% |
| 2009-12-31 | R$2.68 Billion ≈ $525.06 Million |
+62.29% |
| 2008-12-31 | R$1.65 Billion ≈ $323.54 Million |
+29.03% |
| 2007-12-31 | R$1.28 Billion ≈ $250.75 Million |
+353.43% |
| 2006-12-31 | R$281.83 Million ≈ $55.30 Million |
+29.69% |
| 2005-12-31 | R$217.30 Million ≈ $42.64 Million |
-- |
About Hypera S.A
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamm… Read more